|
| Press Releases |
|
 |
|
| Thursday, June 19, 2025 |
|
|
ULVAC Continues Participation in "Lab-in-Fab" Project to Advance Piezoelectric MEMS Technology, Now Entering a New Phase |
| ULVAC, Inc. announced that the collaborative development project "Lab-in-Fab," aimed at advancing piezoelectric Micro-Electro-Mechanical Systems (piezoMEMS) *1 technology and in which ULVAC has participated since 2020, is entering a new phase. more info >> |
|
| Tuesday, December 6, 2022 |
|
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
| Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore's biologics manufacturing capabilities. more info >> |
|
| Thursday, June 2, 2022 |
|
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR. more info >> |
|
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| more info >> |
|
| Thursday, September 30, 2021 |
|
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
| The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid. AVID is customised for the vaccination centres which are set up by the Ministry of Health and operated by private healthcare providers. more info >> |
|
| Friday, July 31, 2020 |
|
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
| Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving "First Patient First Visit[1]" in Phase 1B. The first dose of ETC-159 has been administered to patients in this new phase of clinical testing, which for the first time, will look at efficacy in addition to assessing the safety of ETC-159 in treating different types of cancers. more info >> |
|
| Friday, July 24, 2020 |
|
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
| MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research (A*STAR). more info >> |
|
| Tuesday, October 22, 2019 |
|
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
| Friday, June 28, 2019 |
|
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
| The nation's drug development efforts have been given additional momentum with the introduction of two new platforms, and a grant scheme for drug discovery and development. more info >> |
|
| Friday, April 5, 2019 |
|
|
Passing of Dr Sydney Brenner, Nobel Laureate, Renowned Pioneer in Molecular Biology, A*Star Senior Fellow |
| It is with deep regret that the Agency for Science, Technology and Research (A*STAR) announces the passing of Dr Sydney Brenner, Honorary Singapore Citizen, and A*STAR Senior Fellow, early this morning. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
GA-ASI and USN Test Expanded Sonobuoy Dispensing System For MQ-9B SeaGuardian(R) 
Jan 14, 2026 02:00 HKT/SGT
|
|
|
Atlas Critical Minerals Commences Trading On NASDAQ Under Ticker Symbol "ATCX"
Jan 13, 2026 21:00 HKT/SGT
|
|
|
Global Sports Brand U.S. Polo Assn. Announced as Official Jersey and Apparel Sponsor for the Legendary Snow Polo World Cup St. Moritz
Jan 13, 2026 20:00 HKT/SGT
|
|
|
Focus Graphite Develops and Validates AI-Enabled Graphite Flake Sizing Technology to Enhance Resource Valuation and Mine Planning
Jan 13, 2026 18:29 HKT/SGT
|
|
|
HKiNEDA Survey Reveals INEDs' Confidence in Hong Kong's Dual-Listing Surge and Digital Frontier
Jan 13, 2026 15:16 HKT/SGT
|
|
|
Mitsubishi Motors Starts Production of Rogue Plug-in Hybrid and Navara OEM Models for Nissan
Jan 13, 2026 16:02 JST
|
|
|
uSMART Opens Admiralty Office and Tai Wai Branch in January
Jan 13, 2026 15:01 HKT/SGT
|
|
|
Additional Investment in Commercial Space Station Business and Acquisition of Experimental Module Usage Rights
Jan 13, 2026 14:34 JST
|
|
|
'Power Women' shaping Asia's tomorrow's cities honoured at ARES 2025 VIP celebration
Jan 13, 2026 12:00 HKT/SGT
|
|
|
Australia Developers Triumph at the 20th PropertyGuru Asia Property Awards Grand Final
Jan 13, 2026 12:00 HKT/SGT
|
|
|
Honda to Adopt New "H mark" as Symbol of Honda Automobile Business
Jan 13, 2026 11:26 JST
|
|
|
Assembly Unifies APAC Network Under One Brand to Build Asia's Leading Tech-Powered Brand Performance Agency
Jan 13, 2026 10:00 HKT/SGT
|
|
|
Eisai and Nuvation Bio Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside the U.S., China and Japan
Jan 13, 2026 9:50 JST
|
|
|
Germany Buys Eight MQ-9B SeaGuardian(R) RPA Through NSPA
Jan 13, 2026 07:00 HKT/SGT
|
|
|
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Jan 12, 2026 20:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
